Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. - Wikidata - awgldk - TriplyDB

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation.

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation.

http://www.wikidata.org/entity/Q40493282

about

Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status Cellular treatments for spinal cord injury: the time is right for clinical trials Engineering tissue from human embryonic stem cells Generation of diverse neural cell types through direct conversion How to make an oligodendrocyte Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update Extracellular Matrix and Integrins in Embryonic Stem Cell Differentiation Gene delivery strategies to promote spinal cord repair Human embryonic stem cell-derived oligodendrocytes: protocols and perspectives Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review Pluripotent stem cells in regenerative medicine: challenges and recent progress Neural differentiation from pluripotent stem cells: The role of natural and synthetic extracellular matrix Cell sources for the regeneration of articular cartilage: the past, the horizon and the future Directed differentiation of embryonic stem cells using a bead-based combinatorial screening method MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model Stem cells in human neurodegenerative disorders--time for clinical translation?A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders Stem cells for the treatment of neurological disorders Directed Differentiation of Human Embryonic Stem Cells Toward Placode-Derived Spiral Ganglion-Like Sensory Neurons.Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.Stem cell-based models and therapies for neurodegenerative diseases Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis.Complete rat spinal cord transection as a faithful model of spinal cord injury for translational cell transplantation Alternative splicing events identified in human embryonic stem cells and neural progenitors.Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells.Human embryonic stem cell-derived keratinocytes exhibit an epidermal transcription program and undergo epithelial morphogenesis in engineered tissue constructs Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free Conditions.Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.Defined and Scalable Differentiation of Human Oligodendrocyte Precursors from Pluripotent Stem Cells in a 3D Culture System.What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?Cell replacement therapies to promote remyelination in a viral model of demyelination Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.Therapeutic strategies for the treatment of spinal muscular atrophy.Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection.

P2860

Q21135533-E7B4F657-E022-4774-A263-5212BC9E231E Q21999273-DBDBE2AA-5E5C-4536-9FE8-DC497F600239 Q24630772-C4D8A65B-5C0E-46C9-9D4D-2ED224196DD9 Q24657199-D53DD7D3-5623-41C2-A143-467B1F6CA57E Q26765258-DC565002-A23A-42CB-B3D2-A81DD9AE866F Q26775534-226E127C-0AC6-484B-8C63-A8B58C813299 Q26780518-4646D7DC-54E5-4CAA-ADEA-B31E3023D898 Q26783697-FEC10239-9E2F-4C75-AD96-1A3E0C4A7881 Q26825131-957367A7-2BBC-4E43-A85F-97B2C614B735 Q26829414-CCD6A0FC-1954-43FE-B8F9-CEB0CCA2250D Q26861926-801D8684-4C88-4E99-AD22-57D90319543F Q26999292-4A8DAF97-3C48-479E-BDC7-9B34E1E01527 Q27007542-134A6DF4-FE96-41B8-BB50-6B1E7264C28D Q27023782-F4117813-C3D0-45C6-B26C-E612DC1F26D6 Q27316236-2C6CFC61-1C99-47DE-8A04-D9502B57F169 Q27322685-3762768B-048B-44DF-AB83-F58621B50EA8 Q27687068-2E4DCB14-1CD9-4C05-8A74-A99379F5B50A Q28078326-9C4694FE-D4CE-4EFB-AD97-968C6C9122D2 Q28080219-6EC54F1A-EF2B-4AAF-BB2D-074A64C3DB49 Q28249501-3D569187-47C7-4048-8019-2319F71C5CBB Q30354199-5E6CE2F0-0547-4D83-9E48-2F6989708237 Q30395748-DCBE1C60-C22D-4C8E-B472-D071E94A9F6E Q30451005-BC79DB48-B796-4C14-B09A-8052828C4469 Q30514192-05621E32-CD0B-4E8E-B130-4FB610394FB5 Q30514521-F4D05A97-EF59-4F77-9FDF-D69976B5B6AB Q30844257-E29B1AA6-AF5D-405C-8F68-B0A3FA1D8D45 Q33304209-EF85D82D-ED1C-4B77-94F2-974CB8A0EAEB Q33367115-0D2C1599-1889-4BD2-BBCA-2F8A7F652E96 Q33576848-CB1AC803-9706-44B4-8B3F-091190959754 Q33608769-1DD1361A-9503-43D6-BE29-0C3E677F3AE5 Q33651561-F301DF3D-E834-4525-ABDF-ADF6CA84495E Q33722594-E6C5BD56-44A6-4D09-8382-54A354FB52FB Q33740931-216F6E9A-636E-4A76-B173-871EDC2F11C0 Q33795348-E00FE03F-ACF0-4CA1-8AB0-401860D50F5B Q34029285-C809C902-15BA-48B5-A8EC-B1116FCA906C Q34056814-F645882D-AFFA-49F6-918A-F437D54AA095 Q34085826-9D752929-A308-437F-9662-B22661248331 Q34250392-D441E2A4-E662-43AA-8C23-3817A661A346 Q34296140-7DCFBCFD-B6BF-49C1-8438-73378A03A4DD Q34373886-976BC88D-509D-4CE0-9380-443D13520C08

P2860

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation.

http://www.wikidata.org/entity/Q40493282

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Human embryonic stem cells dif ...... r spinal cord transplantation.

@en

type

label

Human embryonic stem cells dif ...... r spinal cord transplantation.

@en

prefLabel

Human embryonic stem cells dif ...... r spinal cord transplantation.

@en

P1433

Q40493282-97668656-9391-41A4-A4F8-6059AECDD7AF

P1476

Q40493282-B545CA21-A72B-4DB6-81FE-57DDC34AD92B

P2093

Q40493282-0140A80C-6ABC-472C-8E9E-609AA58F7B66

Q40493282-6052F0D9-CD3F-47D2-9AB3-018393603D31

Q40493282-D796E16D-09C4-4FF5-92B4-70206DC243E9

Q40493282-EC96DB09-0541-4455-8D9B-8CA141740EF9

Q40493282-EEA65B84-92E8-4F15-91E8-F8A68BF2D336

P304

Q40493282-816DB004-1EF2-4FE8-AFD8-122DD2DF8F3C

P31

Q40493282-DFC42BBB-F67B-411C-8A83-6E0AA49914FA

P356

Q40493282-B0A1B6BC-7B9A-4C1A-BD01-3FB8D30EDD3F

P433

Q40493282-57C73CE0-67BA-4CF2-8A9C-0CFA5A9AA1F8

P478

Q40493282-2A46B856-519B-4B6C-9CE2-E3276DC05ED7

P577

Q40493282-6499A92E-8566-41AD-B83B-DC3767B6DEE6

P698

Q40493282-A59A95C5-4581-4A54-81CE-93C262A992DF

P921

Q40493282-9150C8AE-5F72-4DB6-86B5-DA0F0C0C0F3F

P356

P1433

P1476

Human embryonic stem cells dif ...... r spinal cord transplantation.

@en

P2093

Gabriel I Nistor

http://www.w3.org/2001/XMLSchema#string

Hans S Keirstead

http://www.w3.org/2001/XMLSchema#string

Melissa K Carpenter

http://www.w3.org/2001/XMLSchema#string

Minodora O Totoiu

http://www.w3.org/2001/XMLSchema#string

Nadia Haque

http://www.w3.org/2001/XMLSchema#string

P304

385-396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GLIA.20127

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15538751

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte